#1 Clinical Trials Search in Europe

Erythromycin

Erythromycin, a versatile antibiotic, is being studied in various clinical trials for its potential benefits beyond its traditional antimicrobial use. These trials explore its effectiveness in treating conditions such as sepsis, bronchiectasis, familial adenomatous polyposis, gastroparesis, and preterm premature rupture of membranes. Researchers are investigating erythromycin’s immunomodulatory properties, prokinetic effects, and ability to induce read-through of genetic mutations.

Table of Contents

What is Erythromycin?

Erythromycin is a versatile antibiotic that belongs to a class of drugs called macrolides. It has been used for many years to treat various bacterial infections and has some unique properties that make it useful for other medical conditions as well. Erythromycin is known by several other names, including E-mycin, Eryc, and Ery-tab[1].

Conditions Treated with Erythromycin

Erythromycin is used to treat a wide range of conditions, including:

  • Bacterial infections: As an antibiotic, erythromycin is primarily used to fight various bacterial infections[2].
  • Gastroparesis: This is a condition where the stomach takes too long to empty its contents. Erythromycin can help speed up stomach emptying[3].
  • Upper gastrointestinal bleeding: Erythromycin can help clear the stomach of blood, making it easier for doctors to see and treat the source of bleeding during an endoscopy (a procedure where a camera is inserted into the stomach)[4].
  • Preterm premature rupture of membranes (PPROM): This is a pregnancy complication where the amniotic sac breaks before 37 weeks of pregnancy. Erythromycin is used to help prolong pregnancy in these cases[5].
  • Bronchiolitis obliterans: This is a rare lung disease that can be caused by exposure to certain chemicals. Erythromycin has been studied for its potential to help in this condition[6].

How Erythromycin Works

Erythromycin works in two main ways:

  1. As an antibiotic: It fights bacteria by preventing them from making proteins they need to survive[2].
  2. As a prokinetic agent: This means it can stimulate movement in the digestive system. It does this by interacting with a receptor called motilin, which helps control the contractions of the stomach and intestines[7].

Interestingly, erythromycin also has some anti-inflammatory effects, which researchers are studying for potential new uses of the drug[2].

Dosage and Administration

The dosage and how erythromycin is given can vary depending on the condition being treated:

  • For bacterial infections, it’s often taken orally (by mouth) multiple times a day for several days[2].
  • For gastroparesis or before an endoscopy for upper gastrointestinal bleeding, it may be given as an intravenous (IV) infusion[4].
  • In pregnancy for PPROM, it may be given IV first, then orally[5].

Always follow your doctor’s instructions for taking erythromycin. The dose and duration of treatment will be tailored to your specific condition.

Potential Side Effects

Like all medications, erythromycin can cause side effects. Some of the more common ones include:

  • Gastrointestinal upset: This can include nausea, vomiting, and stomach pain[5].
  • Cardiac effects: In rare cases, erythromycin can affect heart rhythm. This is more likely when it interacts with certain other medications[3].

Always inform your doctor about all medications you’re taking to avoid potential interactions.

Ongoing Research and Potential New Uses

Researchers are continually studying erythromycin for potential new uses. Some areas of ongoing research include:

  • Sepsis treatment: Studies are looking at whether erythromycin can help modulate the immune response in severe infections[2].
  • Bronchiectasis in children: This is a condition where the airways of the lungs become damaged and widened. Researchers are studying whether long-term, low-dose erythromycin can help manage this condition[8].
  • Familial adenomatous polyposis (FAP): This is a rare genetic condition that can lead to colon cancer. Scientists are investigating whether erythromycin can help correct the genetic defect in this condition[9].

These studies show that even though erythromycin has been around for a long time, researchers are still finding potential new ways it might help patients.

Condition Erythromycin Use Potential Benefits Study Design
Sepsis Immunomodulatory agent Balance pro-inflammatory and anti-inflammatory cytokines Randomized clinical trial
Bronchiectasis Low-dose treatment Improve lung function, reduce exacerbations Prospective, multicenter study
Familial Adenomatous Polyposis Induce read-through of APC gene mutations Reduce adenoma number and size Clinical trial with endoscopic evaluation
Gastroparesis Prokinetic agent Improve gastric emptying and symptoms Comparative study with other prokinetics
Preterm Premature Rupture of Membranes Antibiotic treatment Prolong pregnancy latency Randomized trial comparing with azithromycin

FAQ

  • What is erythromycin being studied for in clinical trials? Erythromycin is being studied for various conditions, including sepsis, bronchiectasis, familial adenomatous polyposis, gastroparesis, and preterm premature rupture of membranes. Researchers are exploring its immunomodulatory, prokinetic, and genetic mutation read-through properties.
  • How is erythromycin being used in sepsis patients? In sepsis patients, erythromycin is being studied for its potential immunomodulatory role. Researchers are investigating whether it can help balance pro-inflammatory and anti-inflammatory cytokines, potentially improving clinical outcomes in critically ill septic patients.
  • What is the potential benefit of erythromycin in bronchiectasis? For bronchiectasis patients, low-dose erythromycin is being studied to determine if it can improve lung function, reduce the frequency of pulmonary exacerbations, and enhance overall quality of life.
  • How is erythromycin being used in familial adenomatous polyposis (FAP) trials? In FAP trials, erythromycin is being investigated for its ability to induce read-through of nonsense mutations in the APC gene. This could potentially lead to the expression of a full-length, functional APC protein, which may help reduce the number and size of adenomas in FAP patients.
  • What role does erythromycin play in gastroparesis treatment? Erythromycin is being studied as a prokinetic agent in gastroparesis treatment. It may help improve gastric emptying and reduce symptoms such as nausea, vomiting, and abdominal pain in patients with delayed gastric emptying.

Ongoing Clinical Trials on Erythromycin

  • Study on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19

    Recruiting

    1 1 1 1
    Investigated drugs:
    Belgium Croatia Czechia Estonia France Germany +7

  • Study on Erythromycin and Neomycin for Preventing Infections After Colorectal Surgery in Patients Undergoing Elective Procedures

    Not yet recruiting

    1 1 1
    Investigated drugs:
    Ireland

Glossary

  • Sepsis: A life-threatening condition caused by the body's extreme response to an infection, which can lead to tissue damage, organ failure, and death if not treated promptly.
  • Bronchiectasis: A chronic lung condition where the airways become abnormally widened, leading to a build-up of excess mucus that makes the lungs more vulnerable to infection.
  • Familial Adenomatous Polyposis (FAP): An inherited disorder characterized by the growth of numerous polyps in the large intestine and rectum, which can lead to colorectal cancer if left untreated.
  • Gastroparesis: A digestive disorder that slows or stops the movement of food from the stomach to the small intestine, causing nausea, vomiting, and abdominal pain.
  • Preterm Premature Rupture of Membranes (PPROM): A condition where the amniotic sac breaks before 37 weeks of pregnancy and before labor starts, increasing the risk of preterm birth and complications.
  • Immunomodulatory: The ability to modify or regulate the immune system's function, either by enhancing or suppressing immune responses.
  • Prokinetic: A type of medication that enhances gastrointestinal motility and improves the movement of contents through the digestive tract.
  • Nonsense mutation: A genetic mutation that results in a premature stop codon, leading to the production of a shortened, often non-functional protein.
  • APC gene: The Adenomatous Polyposis Coli gene, which plays a crucial role in preventing the development of tumors in the colon and rectum.
  • Cytokines: Small proteins released by cells that have specific effects on the interactions and communications between cells, particularly in immune responses.

References

  1. https://clinicaltrials.gov/study/NCT00304187
  2. https://clinicaltrials.gov/study/NCT04665089
  3. https://clinicaltrials.gov/study/NCT01323582
  4. https://clinicaltrials.gov/study/NCT02017379
  5. https://clinicaltrials.gov/study/NCT01556334
  6. https://clinicaltrials.gov/study/NCT00367419
  7. https://clinicaltrials.gov/study/NCT01659619
  8. https://clinicaltrials.gov/study/NCT03966066
  9. https://clinicaltrials.gov/study/NCT02175914